Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Guangzhou Pharmaceutical Company Limited to Set up Subsidiary
Guangzhou Pharmaceutical Company Limited announced that it will set up a wholly owned subsidiary, a Guangzhou-based health industrial company, which will be with a registered capital of RMB 10 million and be engaged in the sale of food, healthcare products and medical equipment.
Latest Developments for Guangzhou Pharmaceutical Co Ltd
- Guangzhou Pharmaceutical Co Ltd Proposes Change Of Auditors
- Guangzhou Pharmaceutical Co Ltd Updates Merger with Guangzhou Baiyunshan Pharmaceutical Co Ltd
- Guangzhou Pharmaceutical Co Ltd Announces No Dividend Payment for FY 2012
- Guangzhou Pharmaceutical Company Limited to Acquire Guangzhou Baiyunshan Pharmaceutical Co.
Latest Key Developments in Pharmaceuticals
- AmerisourceBergen Corp Reaffirms FY 2013 EPS Gudiance-Conference Call
- Immunotec Inc Announces New CEO
- Novo Nordisk A/S Reports Positive Results from First Phase 3 Trial with Long-Acting Factor IX for Treatment of Haemophilia B
- Sanofi SA Announces Positive Results on Pivotal Study of Inhibitor in Myelofibrosis-DJ
- Share this
- Link this
- Digg this
Follow Reuters